DiPasqualeAPreissSDa SilvaTGarconN.Vaccine adjuvants: from 1920 to 2015 and beyond. Vaccines (Basel). 2015;3:320-343.
2.
HePZouYHuZ.Advances in aluminum hydroxide-based adjuvant research and its mechanism. Hum Vaccin Immunother. 2015;11:477-488.
3.
Johns Hopkins Bloomberg School of Public Health. Institute for Vaccine Safety. Package inserts and manufacturers for some U.S. licensed vaccines and immunoglobulins. http://vaccinesafety.edu/package_inserts.htm. Updated April5, 2017. Accessed April 24, 2017.
US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention/Food and Drug Administration. Vaccine Adverse Event Reporting System (VAERS) 1990-last month, CDC Wonder On-line Database. http://wonder.cdc.gov/vaers.html. Accessed April 21, 2017.
6.
McMillanCSSpougeARIHammerbergOThainLMF. Magnetic resonance imaging for differentiating delayed-onset sterile abscess complicating soft-tissue neoplasm. Can Assoc Radiol J. 2000;51:28-29.
7.
KleinNPEdwardsKMSparksRCDekkerCL; Clinical Immunization Safety Assessment (CISA) Network. Recurrent sterile abscesses following aluminum adjuvant-containing vaccines. BMJ Case Rep. 2009;2009:0951. doi:10.1136/bcr.09.2008.0951.
8.
LehmanHKFadenHSFangYVBallowM.A case of recurrent sterile abscesses following vaccination: delayed hypersensitivity to aluminum. J Pediatr. 2008;152:133-136.
Centers for Disease Control and Prevention. National Center for Health Statistics. Health, United States, 2015—With special feature on racial and ethnic health disparities. https://www.cdc.gov/nchs/data/hus/hus15.pdf#066. Published/Updated May2016. Accessed April 25, 2017.
11.
LindbladEB.Aluminum compounds for use in vaccines. Immunol Cell Biol. 2004;82:497-505.
12.
BergforsEBjorkelundCTrollforsB.Nineteen cases of persistent pruritic nodules and contact allergy to aluminum after injection of commonly used aluminum-adsorbed vaccines. Eur J Pediatr. 2005;164:691-697.
